For those patients who have embryos in long-term storage at ReproTech, we are pleased to share their reassuring statement in regards to the Dobbs v. Jackson ruling:
“On June 24, 2022, the U. S. Supreme Court ruling in the case of Dobbs v. Jackson Women’s Health Organization overturned federal protections for abortion which now provides that each individual state will regulate their own abortion laws. Thirteen states have trigger laws that went, or will go, into effect based on the Dobbs v. Jackson ruling that have abortion restrictions. This has created significant concern and confusion about state’s laws impact on Assisted Reproductive Technology (ART), and we share that concern.
Based on ASRM’s guidance in their Potential Implications for Reproductive Medicine report, ReproTech currently does not expect any impact in the operations at any of our locations. According to the ASRM report, twelve of the thirteen state’s trigger laws that restrict abortion do not appear to include ART in any of their restrictive language. The ASRM document indicates that these states’ trigger laws apply to fertilized embryos in pregnant women, not to embryos in storage that were created with ART. The Utah trigger law is the one exception that has language that could be interpreted to have an impact on ART.
We understand that some of our partners clinics may feel it is in the best interest of their patients to begin working with a ReproTech facility in a more IVF “friendly” state. However, ReproTech’s facilities are strategically located throughout the U.S. to provide the highest level of service to your patients. Working with the ReproTech facility closest to you allows us to provide the most convenient and economical service for your patients and reduce shipping distances.
ReproTech is exceptionally positioned and fortunate to have nationwide locations in 5 states that give us the flexibility to continuing providing all cryostorage and dispositions options to your patients. Should the laws concerning disposition of embryos change in one of the states where ReproTech is located, and if any of your patients’ disposition choices are restricted, they will always have the ability to transfer their embryos to one of ReproTech’s other four nationwide locations for disposition.”
